Wake Forest Names VC Board Member Julie Freischlag as CEO

Julie Freischlag headshot

Congratulations to Julie Freischlag, MD, a member of our Board of Directors and current Vice Chancellor for Human Health Sciences and Dean of the School of Medicine at the University of California at Davis. Dr. Freischlag is taking a new position as Chief Executive Officer at Wake Forest Baptist Medical Center in Winston Salem, North Carolina.

 

Vascular Cures Launches Collaborative Patient-Centered Research Grants

Ho_Karen_MD

As part of its mission to advance collaborative relationships across vascular healthcare, Vascular Cures announced the initiation of its Collaborative Patient-Centered Research (CPCR) Grants Program. The awardees are two multi-institutional teams led by Dr. Karen Ho of Northwestern University and Dr. Larry Kraiss at the University of Utah. Each team will receive $100,000 to conduct projects that use shared research resources and will generate results within 1 – 2 years.  Find out more here.

 

UPMC Vascular Surgeon Wins Award to develop non surgical therapies to unblock arteries

Ryan_mcenaney

Vascular Cures and the Society of Vascular Surgery named Ryan McEnaney, MD, University of Pittsburgh Medical Center, as the 2016 Wylie Scholar. The Wylie Scholar Program, now in its 20th year, awards three-year $150,000 research grants to young vascular surgeon-scientists to pursue innovative basic or clinical research projects. It is one of the most important grants for early-stage scientists as it launches their ability to successfully compete for NIH and other grants. Dr. McEnaney is the 19th Wylie Scholar and the 4th Scholar from UMPC. Dr. McEnaney’s research may ultimately lead to the development of medical therapies to unblock arteries for patients for whom surgical procedures are not an option. Dr. McEnaney received his medical degree from the Saint Louis University School of Medicine and completed his residency at UPMC, where he served as administrative chief resident in vascular surgery. He is board certified in vascular surgery. Dr. McEnaney's surgical interests include peripheral vascular disease, aortic aneurysms, venous diseases, and vascular access. His scientific research focuses on the molecular biology and biochemistry of vascular adaptation to occlusive disease. To learn more about Dr. McEnaney's work click here.

 

Vascular Cures Boosts Board Strength with UC Davis Vice Chancellor and UnitedHealthcare Executive

Julie Freischlag headshot

Vascular Cures, the only national non-profit focused on transforming research and health for diseases outside the heart, announced the addition of two new board members: Julie Freischlag, MD, Vice Chancellor for Human Health Sciences and Dean of the School of Medicine at UC Davis and Lori C. McDougal, a former member of the UnitedHealthcare (UHG) executive leadership team and CEO of the UHG Military and Veterans business segment.

"Dr. Freischlag and Ms. McDougal bring unique perspectives on the challenges of health care in the 21st century. Their perspectives will help guide our strategic initiatives to empower patients while supporting life-saving research," said Wendy Hitchcock, Vascular Cures CEO. "As a leader of a major academic health system, Dr. Freischlag knows the opportunities to improve patient outcomes through research, technology and innovative care. And as a senior executive at one of the country's largest health insurers, Ms. McDougal has been at the forefront of developing new models for care delivery to improve health while addressing skyrocketing costs. We are honored to have them join the Vascular Cures' leadership team."

Ms. McDougal is an independent Board member who has engineered transformational 

Lori McDougal Picture 2market expansion across government, commercial and international sectors. Her industry thought leadership helps to align health policy, academic research and market trends to create clarity of insight. As previous CEO and founder of UnitedHealthcare Military and Veterans, she created a $4.1 billion dollar division serving more than 2.9 million military beneficiaries. Dr. Freischlag oversees UC Davis Health System's academic, research and clinical programs including the Schools of Medicine and Nursing, the 1,000-member physician practice group, and UC Davis Medical Center. She is particularly excited about Vascular Cures' new digital health engagement platform, Project Voice, as it is the first unified platform for patient-engagement and patient-reported outcomes research for vascular disease. Her experience as a vascular surgeon showed her the need for such a program to catalyze greater collaboration between patients, researchers, providers and industry. Read the press release here.

 

Washington University Vascular Surgeon Wins Award to Improve Limb Preservation in Diabetic Patients

2460100E3B9313_ForWeb

Vascular Cures has named Mohamed Zayed, MD, PhD, at Washington University School of Medicine, St. Louis, Missouri, as its 2015 Wylie Scholar in Academic Vascular Surgery. The $150,000 multi-year grant, co-sponsored by the Society for Vascular Surgery, was awarded to support Dr. Zayed's research on the role of phospholipids in the progression of peripheral arterial disease in the setting of diabetes. Individuals with chronic diabetes – approximately 20 million Americans, develop a unique pattern of diffuse lower leg peripheral arterial disease, which dramatically increases their risk for poor tissue healing and higher rates of major lower extremity amputations. It is presumed that accelerated arterial plaque development (atheroprogression) and impaired arterial collateral formation (arteriogenesis) contribute to this process, but the molecular processes that lead to this are not yet understood. Dr. Zayed's current research will provide the impetus for future translational studies that aim to improve peripheral arterial patency and limb preservation in diabetic patients. To learn more about Dr. Zayed's work click here.

Vascular Cures' Wylie Scholar Program provides financial assistance to outstanding surgeons at the early stage of their careers to help them develop as academic vascular surgeon-scientists. Vascular Cures has advanced breakthrough research since 1982.

 

Page 1 of 4

<< Start < Prev 1 2 3 4 Next > End >>